Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: Secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples

Genes Chromosomes and Cancer

Volumn 53, Issue 6, 2014, Pages 497-515

  Penas, Eva Maria Murga ^a,b   Schilling, Georgia ^a   Behrmann, Petra ^a   Klokow, Marianne ^a   Vettorazzi, Eik ^a   Bokemeyer, Carsten ^a   Dierlamm, Judith ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 1Q; CHROMOSOME 3P; CHROMOSOME 7Q; CHROMOSOME LOSS; CLINICAL ARTICLE; CYTOGENETICS; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; KARYOTYPING; METAPHASE; PRIORITY JOURNAL;

HUMAN HERPESVIRUS 4;

ADOLESCENT; ADULT; BURKITT LYMPHOMA; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; KARYOTYPE; MALE; YOUNG ADULT;

EID: 84897564314     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22161     Document Type: Article

References (42)

1. American Type Culture Collection Standards Development Organization Workgroup ASN-0002. 2010. Cell line misidentification: the beginning of the end. Nat Rev Cancer 10:441-448.
2. Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM. 2011. Double-hit B-cell lymphomas. Blood 117:2319-2331.
3. Barth TF, Müller S, Pawlita M, Siebert R, Rother JU, Mechtersheimer G, Kitinya J, Bentz M, Möller P. 2004. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement. J Pathol 203:940-945.
4. Berger R, Bernheim A. 1984. Is there a functional equivalence between abnormalities of the long arm of chromosome 1 and the presence of Epstein-Barr virus in continuous lines of Burkitt's lymphoma? C R Acad Sci III 298:143-145.
5. Berger R, Bernheim A. 1985. Cytogenetics of Burkitt's lymphoma-leukaemia: A review. IARC Sci Publ 60:65-80.
6. Boerma EG, Siebert R, Kluin PM, Baudis M. 2009. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge. Leukemia 23:225-234.
7. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. 1982. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79:7824-7827.
8. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project. 2006. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354:2431-2442.
9. Dierlamm J, Wlodarska I, Michaux L, La Starza R, Zeller W, Mecucci C, Van den Berghe H. 1996. Successful use of the same slide for consecutive fluorescence in situ hybridization experiments. Genes Chromosomes Cancer 16:261-264.
10. Dierlamm J, Rosenberg C, Stul M, Pittaluga S, Wlodarska I, Michaux L, Dehaen M, Verhoef G, Thomas J, de Kelver W, Bakker-Schut T, Cassiman JJ, Raap AK, De Wolf-Peeters C, Van den Berghe H, Hagemeijer A. 1997. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 11:747-758.
11. Dierlamm J, Baens M, Stefanova-Ouzounova M, Hinz K, Wlodarska I, Maes B, Steyls A, Driessen A, Verhoef G, Gaulard P, Hagemeijer A, Hossfeld DK, De Wolf-Peeters C, Marynen P. 2000. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 96:2215-2218.
12. Douglass EC, Magrath IT, Lee EC, Whang-Peng J. 1980. Serial cytogenetic studies of nonendemic Burkitt's lymphoma cell lines. J Natl Cancer Inst 65:891-895.
13. Drexler HG, Matsuo AY, MacLeod RA. 2000. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. Leuk Res 24:881-911.
14. Drexler HG, Dirks WG, Matsuo Y, MacLeod RA. 2003. False leukemia-lymphoma cell lines: An update on over 500 cell lines. Leukemia 17:416-426.
15. Duensing S, Münger K. 2002. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62:7075-7082.
16. Einerson RR, Law ME, Blair HE, Kurtin PJ, McClure RF, Ketterling RP, Flynn HC, Dogan A, Remstein ED. 2006. Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2. Leukemia 20:1790-1799.
17. Finter NB. 1987. Human cells as a source of interferons for clinical use. J Interferon Res 7:497-500.
18. Garcia JL, Hernandez JM, Gutierrez NC, Flores T, González D, Calasanz MJ, Martínez-Climent JA, Piris MA, Lopéz-Capitán C, González MB, Odero MD, San Miguel JF. 2003. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study. Leukemia 17:2016-2024.
19. Havelange V, Ameye G, Théate I, Callet-Bauchu E, Mugneret F, Michaux L, Dastugue N, Penther D, Barin C, Collonge-Rame MA, Baranger L, Terré C, Nadal N, Lippert E, Laï JL, Cabrol C, Tigaud I, Herens C, Hagemeijer A, Raphael M, Libouton JM, Poirel HA. 2013. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement. Genes Chromosomes Cancer 52:81-92.
20. Hiller B, Bradtke J, Balz H, Rieder H. 2004. "CyDAS Online Analysis Site". Available at: http://www.cydas.org/OnlineAnalysis/.
21. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, Kühn M, Lenze D, Lichter P, Martin-Subero JI, Möller P, Müller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Stürzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Trümper L, Stein H, Siebert R. Molecular mechanisms in malignant lymphomas network project of the Deutsche Krebshilfe. 2006. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419-2430.
22. Jaffe ES, Harris NL, Stein H, Vardiman JW. 2001. World Health Organization classification of tumours. Tumours of Haematopoietic and Lymphoid Tissue. Lyon: IARC Press, pp. 135-137.
23. Karpova MB, Schoumans J, Ernberg I, Henter JI, Nordenskjöld M, Fadeel B. 2005. Raji revisited: cytogenetics of the original Burkitt's lymphoma cell line. Leukemia 19:159-161.
24. Karpova MB, Schoumans J, Blennow E, Ernberg I, Henter JI, Smirnov AF, Nordenskjöld M, Fadeel B. 2006. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines. Int J Oncol 28:605-617.
25. Kenney JL, Guinness ME, Curiel T, Lacy J. 1998. Antisense to the epstein-barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells. Blood 92:1721-1727.
26. Lones MA, Sanger WG, Le Beau MM, Heerema NA, Sposto R, Perkins SL, Buckley J, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Finlay J, Bergeron S, Cairo MS; Children's Cancer Group Study CCG-E08. 2004. Chromosome abnormalities may correlate with poor prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents. J Pediatr Hematol Oncol 26:169-178.
27. Man C, Rosa J, Lee LTO, Lee VHY, Chow BKC, Lo KW, Doxsey S, Wu ZG, Kwong YL, Jin DY, Cheung ALM, Tsao SW. 2007. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells. Oncogene 26:3069-3080.
28. May PC, Foot N, Dunn R, Geoghegan H, Neat MJ. Detection of cryptic and variant IGH-MYC rearrangements in high-grade non-Hodgkin's lymphoma by fluorescence in situ hybridization: Implications for cytogenetic testing. 2010. Cancer Genet Cytogenet 198:71-75.
29. Mitelman F, Johansson B, Mertens F editors. 2011. Mitelman Database of Chromosome Aberrations in Cancer. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman.
30. Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JA, Lyden ER, Heerema NA, Lones MA, Harrison L, Cairo MS, Sanger WG. 2010. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: Results from the Children's Oncology Group study CCG-5961. Br J Haematol 148:600-610.
31. Onciu M, Schlette E, Zhou Y, Raimondi SC, Giles FJ, Kantarjian HM, Medeiros LJ, Ribeiro RC, Pui CH, Sandlund JT. 2006. Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma. Cancer 107:1084-1092.
32. Parsa NZ, Gaidano G, Mukherjee AB, Hauptschein RS, Lenoir G, Dalla-Favera R, Chaganti RS. 1994. Cytogenetic and molecular analysis of 6q deletions in Burkitt's lymphoma cell lines. Genes Chromosomes Cancer 9:13-18.
33. Poirel HA, Cairo MS, Heerema NA, Swansbury J, Aupérin A, Launay E, Sanger WG, Talley P, Perkins SL, Raphaël M, McCarthy K, Sposto R, Gerrard M, Bernheim A, Patte C; FAB/LMB 96 International Study Committee. 2009. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Leukemia 23:323-331.
34. Salaverria I, Zettl A, Beà S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC, Weisenburger DD, Lopez-Guillermo A, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Jaffe ES, Staudt LM, Müller-Hermelink HK, Campo E, Rosenwald A; Leukemia and Lymphoma Molecular Profiling Project (LLMPP). 2008. Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma. Haematologica 93:1327-1334.
35. Scholtysik R, Kreuz M, Klapper W, Burkhardt B, Feller AC, Hummel M, Loeffler M, Rosolowski M, Schwaenen C, Spang R, Stein H, Thorns C, Trümper L, Vater I, Wessendorf S, Zenz T, Siebert R, Küppers R; Molecular Mechanisms in Malignant Lymphomas Network Project of Deutsche Krebshilfe. 2010. Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis. Haematologica 95:2047-2055.
36. Shaffer LG, McGowan-Jordan J, Schmid M, editors. 2013. ISCN (2013): An International System for Human Cytogenetic Nomenclature (2013). Basel, Switzerland: S Karger.
37. Sobol H, Benziane A, Kerangueven F, Yin L, Noguchi T, Pauly S, Eisinger F, Longy M, Romeo G, Lenoir G, Birnbaum D. 2002. Genome-wide search for loss of heterozygosity in Burkitt lymphoma cell lines. Genes Chromosomes Cancer 33:217-224.
38. Tagawa H, Karube K, Tsuzuki S, Ohshima K, Seto M. 2010. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci 98:1482-1490.
39. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P. 1982. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79:7837-7841.
40. Thorley-Lawson DA, Allday MJ. 2008. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol 6:913-924.
41. Toujani S, Dessen P, Ithzar N, Danglot G, Richon C, Vassetzky Y, Robert T, Lazar V, Bosq J, Da Costa L, Pérot C, Ribrag V, Patte C, Wiels J, Bernheim A. 2009. High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma. PLoS One 4:e7089.
42. Yasunaga J, Jeang K-T. 2009. Viral transformation and aneuploidy. Environ Mol Mutagen 50:733-740.